What You Should Know
- The Lawsuits: Several startup founders, including PatchAi’s Alessandro Monterosso and RedCrow’s Jerry Harrison (of the Talking Heads), are suing Alira Health and CEO Gabriele Brambilla for fraud, unjust enrichment, and Securities Exchange Act violations.
- The Alleged Scheme: The founders claim Brambilla orchestrated a systematic freeze-out. Alira allegedly acquired startups using inflated stock, set impossible performance goals to justify firing the founders, and then artificially depressed the company’s valuation to buy back the founders’ shares for a fraction of the cost.
- The SEC Involvement: The fallout has escalated beyond civil court, with an official investor complaint filed with the U.S. Securities and Exchange Commission (SEC) alleging that Alira manipulated redemption calculations and failed to adhere to its Operating Agreement.
The Alleged Playbook: Acquire, Fire, and Devalue
According to an amended complaint filed this week by Monterosso, Alira’s strategy was as ruthless as it was calculated. In 2021, Alira acquired four startups, including PatchAi, largely compensating the founders with Alira stock. The lawsuit alleges that Brambilla intentionally made promises to shareholders regarding anticipated performance that were “exaggerated and unrealistic in order that they would not be met”. When those startups inevitably missed the impossible targets, Alira used the failure as grounds to terminate the founders’ employment.
Under their operating agreements, termination triggered Alira’s right to buy back the founders’ shares. Monterosso claims that Brambilla “directly controlled the valuation process” and deliberately altered valuation methodologies year by year to suppress Alira’s stock price right when the buybacks occurred.
The result? The founders were forced to sell their equity back to Alira for a fraction of its original value, while Brambilla allegedly protected his own wealth and the interests of major backers.
The RedCrow Revolt
Monterosso is not fighting alone. RC Crowd Holdings, LLC and co-founders Jerry Harrison and Brian Smith are also pursuing litigation regarding Alira’s acquisition of their healthcare crowdfunding platform, RedCrow. They allege false and misleading representations, claiming Alira failed to provide promised operational funding, effectively starving the platform and preventing the founders from earning performance-based payouts.
The SEC Steps In
The investor complaint filed with the U.S. Securities and Exchange Commission (SEC), alleging that Alira Health manipulated redemption calculations and brazenly ignored its own Operating Agreement, resulting in massive shareholder losses.
Dangers of Acquition Earn-Outs/Stock Buybacks
Acquisition earn-outs and stock buybacks are notoriously contentious, but the allegations against Alira Health suggest a deliberate strategy to marginalize acquired founders. If these founders can prove that Alira artificially manipulated its own valuation to engineer a “cheap” buyout of its acquired talent, it will serve as a stark warning to the entire health-tech ecosystem: when taking equity in an acquisition, the valuation you sell at doesn’t matter if the buyer controls the calculator when you leave.
